MAR 20, 2015 10:44 AM PDT

Alzheimer's Drug Slows Cognitive Decline

WRITTEN BY: Judy O'Rourke
Biogen Idec Inc, Cambridge, Mass, says aducanumab, its new Alzheimer's drug under development shows signs of slowing the decline of a small number of patients with early indications and mild cases of the disease, according to The Boston Globe.

The company says its testing yielded "statistically significant" evidence the drug slows the decline of certain patients and reduced amyloid plaque in the brain (implicated in the development of Alzheimer's symptoms).
Beta-amyloid is chemically
Biogen says it plans to advance the drug compound to late-stage clinical trials, with FDA approval, and would start to enroll patients later this year.

The newspaper reports the company presented more detailed study results at the International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders.

Pharma giant Eli Lilly & Co is also working on an experimental drug for the disease.

More than 5 million Americans suffer from Alzheimer's. Treatments are available to help mitigate symptoms, but there is presently no cure for the disease.

[Source: The Boston Globe]
About the Author
  • Judy O'Rourke worked as a newspaper reporter before becoming chief editor of Clinical Lab Products magazine. As a freelance writer today, she is interested in finding the story behind the latest developments in medicine and science, and in learning what lies ahead.
You May Also Like
DEC 01, 2019
Neuroscience
DEC 01, 2019
Are teens addicted to their phones?
Journalists quickly jumped to the conclusion that 23% of teenagers are addicted to their smartphones thanks to findings from a new study from King’s ...
DEC 02, 2019
Drug Discovery & Development
DEC 02, 2019
New Ultrasound Treatment for Parkinson's Tremors
A non-invasive ultrasound procedure may provide lasting relief from tremors in people with Parkinson’s disease (PD) and essential tremor (ET), accord...
DEC 19, 2019
Drug Discovery & Development
DEC 19, 2019
Upcoming Psychedelic Cure for Addiction Derived from African Shrub
Every year, almost 70,000 people die from an overdose in the US. Now, a company called MindMed is testing a compound derived from ibogaine, a West African ...
DEC 29, 2019
Cell & Molecular Biology
DEC 29, 2019
How close are we to a simple blood test for Parkinson's Disease?
Parkinson’s Disease (PD) alters nerve cells in the brain that produce the neurotransmitter dopamine. Famously regarded as the “happiness”...
JAN 07, 2020
Cell & Molecular Biology
JAN 07, 2020
Cancer-Like Metabolism Can Fuel Brain Growth
During evolution, the size of the human brain increased significantly compared to other primates....
FEB 26, 2020
Genetics & Genomics
FEB 26, 2020
Optogenetic Techniques Provide Insight Into ALS
In humans, motor neurons link thoughts with the motion of the body. Now researchers have learned more about how they are impacted by ALS....
Loading Comments...